Three new cytotoxic aryltetralin lignans from Sinopodophyllum emodi.

Three new aryltetralin lignans, 4-acetyl-4-demethyl-podophyllotoxin (1) and sinolignans A, B (2-3), and two new natural products (4-5), were isolated from the roots and rhizomes of Sinopodophyllum emodi together with twelve known lignans (6-17). Their structures and stereochemistry were elucidated on the basis of spectroscopic evidence, and circular dichroism (CD) method. The cytotoxic activities of all isolated compounds were evaluated against HeLa and KB cell lines. Compared with etoposide, compounds 1, 6-9, and 13 showed more potent cytotoxicities against two tumor cell lines. On the basis of IC(50) values, deoxypodophyllotoxin (7) was about 579 and 1123 times more toxic than etoposide in HeLa and KB cell lines, respectively. The preliminary SAR study indicated that an oxygenated group at C-7' might decrease cytotoxicity against two cell lines, which was different from most previous studies. However, this needs to be systematically verified by extensive pharmacological experiments.

[1]  A. Nagatsu,et al.  New lignan glycosides from Chinese medicinal plant, Sinopodophillum emodi. , 2003, Chemical & pharmaceutical bulletin.

[2]  Atta-ur-rahman,et al.  Antifungal aryltetralin lignans from leaves of Podophyllum hexandrum , 1995 .

[3]  M. Litaudon,et al.  Sesquiterpenoids and cytotoxic lignans from the bark of Libocedrus chevalieri. , 2007, Journal of natural products.

[4]  M. Gordaliza,et al.  Antitumor properties of podophyllotoxin and related compounds. , 2000, Current pharmaceutical design.

[5]  A. Negi,et al.  Plant-based anticancer molecules: a chemical and biological profile of some important leads. , 2005, Bioorganic & medicinal chemistry.

[6]  Li-ping Wang,et al.  A New Podophyllotoxin-Type Lignan from Dysosma versipellis var. tomentosa , 1991 .

[7]  M. Iinuma,et al.  A new and known cytotoxic aryltetralin-type lignans from stems of Bursera graveolens. , 2005, Chemical & pharmaceutical bulletin.

[8]  P. Dewick,et al.  Aryltetralin lignans from Podophyllum hexandrum and Podophyllum peltatum , 1984 .

[9]  Gang Chen,et al.  Steroidal saponins from Tribulus terrestris , 2009, Steroids.

[10]  A. Nagatsu,et al.  Three new glycosides from Sinopodophyllum emodi (Wall.) Ying. , 2001, Chemical & pharmaceutical bulletin.

[11]  S. Cho,et al.  Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles. , 1999, Journal of medicinal chemistry.

[12]  Y. Cheng,et al.  Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II. , 1990, Journal of medicinal chemistry.

[13]  T. Nakanishi,et al.  New phenylpropanoid glycosides from Juniperus communis var. depressa. , 2010, Chemical & pharmaceutical bulletin.

[14]  A. Dantzig,et al.  Cytotoxic responses to aromatic ring and configurational variations in alpha-conidendrin, podophyllotoxin, and sikkimotoxin derivatives. , 2001, Journal of medicinal chemistry.

[15]  I. Ionkova,et al.  Isolation and Structure Elucidation of Aryltetralin Lignans from Linum tauricum ssp. bulgaricum , 2006 .

[16]  Y. Liu,et al.  Podophyllotoxin: Current Perspectives , 2007 .

[17]  G. Tan,et al.  Bioactive constituents from roots of Bursera tonkinensis. , 2005, Phytochemistry.

[18]  K. Lee,et al.  Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives. , 2004, Journal of medicinal chemistry.

[19]  I. Ionkova.  Anticancer compounds from in vitro cultures of rare medicinal plants , 2008 .

[20]  M. Gordaliza,et al.  Synthesis and cytotoxicity of podophyllotoxin analogues modified in the A ring. , 2003, European journal of medicinal chemistry.

[21]  K. Lee.  Current developments in the discovery and design of new drug candidates from plant natural product leads. , 2004, Journal of natural products.

[22]  Yanyan Zhu,et al.  Lignan glucoside from Sinopodophyllum emodi and its cytotoxic activity , 2011 .

[23]  Ying-Jun Zhang,et al.  Spirostanol and furostanol glycosides from the fresh tubers of Polianthes tuberosa. , 2004, Journal of natural products.

[24]  P. Dewick,et al.  Aryltetralin lignans from Linum flavum and Linum capitatum. , 1990 .

[25]  C. Alemán,et al.  DFT-GIAO study of aryltetralin lignan lactones: conformational analyses and chemical shifts calculations. , 2005, Bioorganic chemistry.

[26]  A. Nagatsu,et al.  Two new podophyllotoxin glucosides from Sinopodophyllum emodi (Wall.) Ying. , 2001, Chemical & pharmaceutical bulletin.

[27]  E. Rúveda,et al.  13C NMR analysis of podophyllotoxin and some of its derivatives , 1980 .

[28]  M. Heinrich,et al.  Cytotoxic activity of a podophyllotoxin-like lignan from Linum tauricum Willd. , 2005, Neoplasma.

[29]  Rakesh K. Sharma,et al.  Cytotoxic and radioprotective effects of Podophyllum hexandrum. , 2006, Environmental toxicology and pharmacology.